In phase III trial, bevacizumab prolongs progression-free survival for ovarian cancer Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Tuesday, November 12, 2013

In phase III trial, bevacizumab prolongs progression-free survival for ovarian cancer



IMNG Oncology Report

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.